Abstract

Withaferin A (WA), a manifold studied, C28-steroidal lactone withanolide found in Withania somnifera. Given its unique beneficial effects, it has gathered attention in the era of modern science. Cancer, being considered a “hopeless case and the leading cause of death worldwide, and the available conventional therapies have many lacunae in the form of side effects. The poly pharmaceutical natural compound, WA treatment, displayed attenuation of various cancer hallmarks by altering oxidative stress, promoting apoptosis, and autophagy, inhibiting cell proliferation, reducing angiogenesis, and metastasis progression. The cellular proteins associated with antitumor pathways were also discussed. WA structural modifications attack multiple signal transduction pathways and enhance the therapeutic outcomes in various diseases. Moreover, it has shown validated pharmacological effects against multiple neurodegenerative diseases by inhibiting acetylcholesterinases and butyrylcholinesterases enzyme activity, antidiabetic activity by upregulating adiponectin and preventing the phosphorylation of peroxisome proliferator-activated receptors (PPARγ), cardioprotective activity by AMP-activated protein kinase (AMPK) activation and suppressing mitochondrial apoptosis. The current review is an extensive survey of various WA associated disease targets, its pharmacokinetics, synergistic combination, modifications, and biological activities.

Highlights

  • Phytotherapy is the frequent therapeutic approach in complementary as well as in traditional medicine since time immemorial

  • Withaferin A (WA) down-regulates the expression of Notch1, pAKT, and NF-κB and other markers of inflammation (interleukin-6 (IL-6), tumor necrosis factor alpha (TNFα), and cyclooxygenase-2) [79], highlighting that this therapeutic agent has a vital role in colon carcinogenesis prevention

  • Various pathways involve kelch like ECH associated protein 1, glycogen synthase kinase 3 [154]. These findings suggest that WA effectively protects cells from Nonalcoholic steatohepatitis (NASH), further studies are still required to know the exact mechanism

Read more

Summary

Introduction

Phytotherapy is the frequent therapeutic approach in complementary as well as in traditional medicine since time immemorial It is utilized by 60% of the global population and has a vital role in the health care system due to ease of availability and reduced cost compared with synthetic compounds. Today medicinal plantsmedicinal are evaluated modern technologies, technologies, including screening and functional assays [8]. Alkylation nucleophilic site chemical structure displayed positions that mayproteins. Nucleophilic site binding reactions occurs through the A-ring at position C3 and the epoxide. These sites are most vulnerable attack reaction; WAalkylation interacts network in C24. The current review is an extensive survey of various WA associated disease targets, summarizing the pharmacokinetics, structural modifications, potential pharmacological activities, and WA formulations, and evaluating the available evidence to predict the potential targets. More than 150 References, indexed in the most relevant data basis (MDPI, ESEVIER, PubMed, NCBI, Springer, etc.) were found describing parts of our topic

Pharmacokinetics and Bioavailability Studies of Withaferin A
Structural Modifications of Withaferin A
Anti-Cancer Activity
Breast Cancer
Ovarian Cancer
Prostate Cancer
Colorectal Cancer
Lung Cancer
WA-Responsive Proteins in Cancer
Anti Diabetic Activity
Neuroprotective Activity
Cardioprotective Activity
COVID 19
Anti Hepatitis Activity
Osteoporosis
Formulations Prepared from Withaferin A
Synergistic Combination of Withaferin A
Findings
Conclusions and Future Perspectives
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call